EICHOR
● Recruiting
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Condition: Non Small Cell Lung Cancer · Esophageal Cancer · Gastric Cancer · Sponsor: University of Missouri-Columbia
About this study
Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite surgery. Also, early detection of lung cancer with low dose CT screening may cure patients at an early stage. Circulating and disseminated tumor cell (CTC/DTC) and circulating cell-free (cf) DNA isolation from the blood, urine and bone marrow will increase understanding of cancer spread and advance knowledge to develop individualized therapies and improve screening.
This description comes directly from the study's public registry record.
Talk to the study team
Jussuf T Kaifi, MD · 5738146565 · jussuf.kaifi@va.gov
Jussuf T Kaifi, MD · 5738146565 · kaifij@health.missouri.edu
Always discuss trial participation with your own doctor first.
Locations (1)
| Harry S Truman Veterans Memorial Hospital | Columbia, Missouri, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.